{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T17:29:29Z","timestamp":1773077369035,"version":"3.50.1"},"reference-count":65,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Renal Nutrition"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1053\/j.jrn.2011.10.021","type":"journal-article","created":{"date-parts":[[2011,12,24]],"date-time":"2011-12-24T14:16:31Z","timestamp":1324736191000},"page":"120-127","source":"Crossref","is-referenced-by-count":22,"title":["Cardiovascular Biomarkers in Chronic Kidney Disease"],"prefix":"10.1053","volume":"22","author":[{"given":"Sun-Hee","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Stenvinkel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bengt","family":"Lindholm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.jrn.2011.10.021_bib1","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jrn.2011.10.021_bib2","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1136\/bmj.39001.657755.BE","article-title":"Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey","volume":"333","author":"Hallan","year":"2006","journal-title":"BMJ"},{"key":"10.1053\/j.jrn.2011.10.021_bib3","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1001\/jama.290.7.898","article-title":"Prevalence of conventional risk factors in patients with coronary heart disease","volume":"290","author":"Khot","year":"2003","journal-title":"JAMA"},{"key":"10.1053\/j.jrn.2011.10.021_bib4","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/ije\/dyn217","article-title":"Critical appraisal of CRP measurement for the prediction of coronary heart disease events: new data and systematic review of 31 prospective cohorts","volume":"38","author":"Shah","year":"2009","journal-title":"Int J Epidemiol"},{"key":"10.1053\/j.jrn.2011.10.021_bib5","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1161\/CIRCULATIONAHA.109.901413","article-title":"Contribution of 30 biomarkers to 10-year cardiovascular risk estimation in 2 population cohorts: the MONICA, risk, genetics, archiving, and monograph (MORGAM) biomarker project","volume":"121","author":"Blankenberg","year":"2010","journal-title":"Circulation"},{"key":"10.1053\/j.jrn.2011.10.021_bib6","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","article-title":"Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis","volume":"375","author":"Matsushita","year":"2010","journal-title":"Lancet"},{"issue":"2 Suppl 1","key":"10.1053\/j.jrn.2011.10.021_bib7","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"39","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.jrn.2011.10.021_bib8","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","article-title":"Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure","volume":"42","author":"Chobanian","year":"2003","journal-title":"Hypertension"},{"key":"10.1053\/j.jrn.2011.10.021_bib9","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study","volume":"364","author":"Yusuf","year":"2004","journal-title":"Lancet"},{"key":"10.1053\/j.jrn.2011.10.021_bib10","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2215\/CJN.03670807","article-title":"Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle?","volume":"3","author":"Stenvinkel","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2011.10.021_bib11","unstructured":"U.S. Renal Data System, USRDS 2009 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United State. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; Bethesda, MD, 2009."},{"key":"10.1053\/j.jrn.2011.10.021_bib12","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000201014","article-title":"KDOQI hypertension, dyslipidemia, and diabetes care guidelines and current care patterns in the United States CKD population: National Health and Nutrition Examination Survey 1999-2004","volume":"30","author":"Snyder","year":"2009","journal-title":"Am J Nephrol"},{"key":"10.1053\/j.jrn.2011.10.021_bib13","unstructured":"Stenvinkel P, Herzog CA. Comprehensive clinical nephrology, 4th ed. Floege, Johnson, and Feehally. St. Louis, MO: Mosby."},{"key":"10.1053\/j.jrn.2011.10.021_bib14","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1525-139X.2010.00784.x","article-title":"Inflammation in end-stage renal disease\u2013what have we learned in 10 years?","volume":"23","author":"Carrero","year":"2010","journal-title":"Semin Dial"},{"key":"10.1053\/j.jrn.2011.10.021_bib15","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1093\/ndt\/gfq273","article-title":"Variations in C-reactive protein during a single haemodialysis session do not associate with mortality","volume":"25","author":"Meuwese","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.jrn.2011.10.021_bib16","unstructured":"Oldani S. Plasma Pentraxin-3 as a marker of bio-incompatibility in haemodialysis patients. J Nephrol. In press."},{"key":"10.1053\/j.jrn.2011.10.021_bib17","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1046\/j.1523-1755.1999.00273.x","article-title":"Inflammation enhances cardiovascular risk and mortality in hemodialysis patients","volume":"55","author":"Zimmermann","year":"1999","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2011.10.021_bib18","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1053\/ajkd.1998.v32.pm9669431","article-title":"Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients","volume":"32","author":"Bologa","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.jrn.2011.10.021_bib19","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1093\/ndt\/gfg066","article-title":"White blood cells as a novel mortality predictor in haemodialysis patients","volume":"18","author":"Reddan","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.jrn.2011.10.021_bib20","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1046\/j.1365-2796.2003.01180.x","article-title":"Fibrinogen, mortality and incident cardiovascular complications in end-stage renal failure","volume":"254","author":"Zoccali","year":"2003","journal-title":"J Intern Med"},{"key":"10.1053\/j.jrn.2011.10.021_bib21","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0272-6386(99)70014-4","article-title":"High serum hyaluronan indicates poor survival in renal replacement therapy","volume":"34","author":"Stenvinkel","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.jrn.2011.10.021_bib22","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1053\/j.ajkd.2006.03.047","article-title":"Serum myeloperoxidase and mortality in maintenance hemodialysis patients","volume":"48","author":"Kalantar-Zadeh","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.jrn.2011.10.021_bib23","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1093\/ndt\/gfq012","article-title":"Circulating monocyte subpopulations with high expression of angiotensin-converting enzyme predict mortality in patients with end-stage renal disease","volume":"25","author":"Ulrich","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.jrn.2011.10.021_bib24","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/qjmed\/hcn019","article-title":"The long pentraxin PTX-3 in prevalent hemodialysis patients: associations with comorbidities and mortality","volume":"101","author":"Suliman","year":"2008","journal-title":"QJM"},{"key":"10.1053\/j.jrn.2011.10.021_bib25","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1159\/000082014","article-title":"C-reactive protein in end-stage renal disease: are there reasons to measure it?","volume":"23","author":"Stenvinkel","year":"2005","journal-title":"Blood Purif"},{"key":"10.1053\/j.jrn.2011.10.021_bib26","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJM199704033361401","article-title":"Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men","volume":"336","author":"Ridker","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jrn.2011.10.021_bib27","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1161\/01.CIR.0000120707.98922.E3","article-title":"C-reactive protein modulates risk prediction based on the Framingham Score: implications for future risk assessment: results from a large cohort study in southern Germany","volume":"109","author":"Koenig","year":"2004","journal-title":"Circulation"},{"key":"10.1053\/j.jrn.2011.10.021_bib28","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1093\/ndt\/gfm951","article-title":"Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study","volume":"23","author":"Panichi","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.jrn.2011.10.021_bib29","first-page":"715","article-title":"Ceruloplasmin and acute phase protein levels are associated with cardiovascular disease in chronic dialysis patients","volume":"17","author":"Panichi","year":"2004","journal-title":"J Nephrol"},{"key":"10.1053\/j.jrn.2011.10.021_bib30","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1093\/ndt\/17.9.1684","article-title":"Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment","volume":"17","author":"Pecoits-Filho","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.jrn.2011.10.021_bib31","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1053\/j.ajkd.2005.09.014","article-title":"Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD","volume":"47","author":"Honda","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.jrn.2011.10.021_bib32","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1053\/j.ajkd.2004.09.018","article-title":"Plasma interleukin-6 predicts cardiovascular mortality in hemodialysis patients","volume":"45","author":"Rao","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.jrn.2011.10.021_bib33","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1093\/ndt\/gfh052","article-title":"Interleukin-6 is a stronger predictor of total and cardiovascular mortality than C-reactive protein in haemodialysis patients","volume":"19","author":"Panichi","year":"2004","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl 1","key":"10.1053\/j.jrn.2011.10.021_bib34","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1681\/ASN.2004110972","article-title":"Inflammation markers, adhesion molecules, and all-cause and cardiovascular mortality in patients with ESRD: searching for the best risk marker by multivariate modeling","volume":"16","author":"Tripepi","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2011.10.021_bib35","doi-asserted-by":"crossref","first-page":"c51","DOI":"10.1159\/000088923","article-title":"Interleukin-8 is a powerful prognostic predictor of all-cause and cardiovascular mortality in dialytic patients","volume":"102","author":"Panichi","year":"2006","journal-title":"Nephron Clin Pract"},{"key":"10.1053\/j.jrn.2011.10.021_bib36","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2215\/CJN.00870207","article-title":"Plasma pentraxin 3 in patients with chronic kidney disease: associations with renal function, protein-energy wasting, cardiovascular disease, and mortality","volume":"2","author":"Tong","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2011.10.021_bib37","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1093\/ndt\/gfl747","article-title":"Pentraxin 3 is elevated in haemodialysis patients and is associated with cardiovascular disease","volume":"22","author":"Boehme","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.jrn.2011.10.021_bib38","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1161\/ATVBAHA.110.217745","article-title":"S100A12 in vascular smooth muscle accelerates vascular calcification in apolipoprotein E-null mice by activating an osteogenic gene regulatory program","volume":"31","author":"Hofmann Bowman","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1053\/j.jrn.2011.10.021_bib39","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.2215\/CJN.03360410","article-title":"Effect of circulating soluble receptor for advanced glycation end products (sRAGE) and the proinflammatory RAGE ligand (EN-RAGE, S100A12) on mortality in hemodialysis patients","volume":"5","author":"Nakashima","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2011.10.021_bib40","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1161\/hy1001.096358","article-title":"Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease","volume":"38","author":"Blacher","year":"2001","journal-title":"Hypertension"},{"key":"10.1053\/j.jrn.2011.10.021_bib41","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00223-010-9372-1","article-title":"Sclerostin: current knowledge and future perspectives","volume":"87","author":"Moester","year":"2010","journal-title":"Calcif Tissue Int"},{"key":"10.1053\/j.jrn.2011.10.021_bib42","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/eurheartj\/ehp049","article-title":"High serum YKL-40 concentration is associated with cardiovascular and all-cause mortality in patients with stable coronary artery disease","volume":"30","author":"Kastrup","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1053\/j.jrn.2011.10.021_bib43","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1111\/j.1523-1755.2005.00345.x","article-title":"Low fetuin-A levels are associated with cardiovascular death: impact of variations in the gene encoding fetuin","volume":"67","author":"Stenvinkel","year":"2005","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2011.10.021_bib44","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1093\/ndt\/gfh891","article-title":"Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients","volume":"20","author":"Wang","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.jrn.2011.10.021_bib45","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1160\/TH03-08-0572","article-title":"Matrix Gla protein is associated with coronary artery calcification as assessed by electron-beam computed tomography","volume":"91","author":"Jono","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.jrn.2011.10.021_bib46","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1681\/ASN.2010040339","article-title":"Circulating nonphosphorylated carboxylated matrix gla protein predicts survival in ESRD","volume":"22","author":"Schlieper","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2011.10.021_bib47","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1053\/ajkd.2002.31402","article-title":"Increased circulating levels of osteoclastogenesis inhibitory factor (osteoprotegerin) in patients with chronic renal failure","volume":"39","author":"Kazama","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.jrn.2011.10.021_bib48","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0272-6386(03)00655-3","article-title":"The progression of vascular calcification and serum osteoprotegerin levels in patients on long-term hemodialysis","volume":"42","author":"Nitta","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.jrn.2011.10.021_bib49","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1681\/ASN.2005030260","article-title":"Plasma osteoprotegerin is associated with mortality in hemodialysis patients","volume":"17","author":"Morena","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2011.10.021_bib50","first-page":"774","article-title":"Inflammation modifies the association of osteoprotegerin with mortality in chronic kidney disease","volume":"22","author":"Matsubara","year":"2009","journal-title":"J Nephrol"},{"key":"10.1053\/j.jrn.2011.10.021_bib51","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1161\/CIRCULATIONAHA.107.707380","article-title":"Osteoprotegerin inhibits vascular calcification without affecting atherosclerosis in ldlr(-\/-) mice","volume":"117","author":"Morony","year":"2008","journal-title":"Circulation"},{"key":"10.1053\/j.jrn.2011.10.021_bib52","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.atherosclerosis.2009.01.001","article-title":"Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community","volume":"205","author":"Mirza","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1053\/j.jrn.2011.10.021_bib53","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1093\/ndt\/gfq309","article-title":"FGF-23 and future cardiovascular events in patients with chronic kidney disease before initiation of dialysis treatment","volume":"25","author":"Seiler","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.jrn.2011.10.021_bib54","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1093\/ndt\/gfp191","article-title":"High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients","volume":"24","author":"Jean","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.jrn.2011.10.021_bib55","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1093\/ndt\/gfq191","article-title":"Relation between serum fibroblast growth factor-23 level and mortality in\u00a0incident dialysis patients: are gender and cardiovascular disease confounding the relationship?","volume":"25","author":"Olauson","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.jrn.2011.10.021_bib56","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1093\/ndt\/gfp067","article-title":"Diagnostic potential of serum biomarkers for left ventricular abnormalities in chronic peritoneal dialysis patients","volume":"24","author":"Wang","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.jrn.2011.10.021_bib57","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1093\/ndt\/gfq557","article-title":"Trimestral variations of C-reactive protein, interleukin-6 and tumour necrosis factor-alpha are similarly associated with survival in haemodialysis patients","volume":"26","author":"Meuwese","year":"2011","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl 1","key":"10.1053\/j.jrn.2011.10.021_bib58","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1111\/j.1540-8159.2008.02259.x","article-title":"Predictive value of repeated versus single N-terminal pro B-type natriuretic peptide measurements early after-myocardial infarction","volume":"32","author":"Sandhu","year":"2009","journal-title":"Pacing Clin Electrophysiol"},{"issue":"Pt 4","key":"10.1053\/j.jrn.2011.10.021_bib59","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1258\/acb.2009.008213","article-title":"Serial increased cardiac troponin T predicts mortality in asymptomatic patients treated with chronic haemodialysis","volume":"46","author":"Roberts","year":"2009","journal-title":"Ann Clin Biochem"},{"key":"10.1053\/j.jrn.2011.10.021_bib60","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/ndt\/gfl605","article-title":"Subclinical hypothyroidism is linked to micro-inflammation and predicts death in continuous ambulatory peritoneal dialysis","volume":"22","author":"Enia","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.jrn.2011.10.021_bib61","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/j.1365-2796.2007.01865.x","article-title":"Clinical and biochemical implications of low thyroid hormone levels (total and free forms) in euthyroid patients with chronic kidney disease","volume":"262","author":"Carrero","year":"2007","journal-title":"J Intern Med"},{"key":"10.1053\/j.jrn.2011.10.021_bib62","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1056\/NEJMoa0707064","article-title":"Use of multiple biomarkers to improve the prediction of death from cardiovascular causes","volume":"358","author":"Zethelius","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jrn.2011.10.021_bib63","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1111\/j.1523-1755.2005.00338.x","article-title":"Prognostic value of combined use of biomarkers of inflammation, endothelial dysfunction, and myocardiopathy in patients with ESRD","volume":"67","author":"Mallamaci","year":"2005","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2011.10.021_bib64","doi-asserted-by":"crossref","first-page":"72","DOI":"10.2215\/CJN.03860609","article-title":"Predicting six-month mortality for patients who are on maintenance hemodialysis","volume":"5","author":"Cohen","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2011.10.021_bib65","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.2215\/CJN.00940208","article-title":"Utility of the \u201csurprise\u201d question to identify dialysis patients with high mortality","volume":"3","author":"Moss","year":"2008","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Journal of Renal Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051227611002111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051227611002111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T06:44:21Z","timestamp":1561099461000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1051227611002111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":65,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S1051227611002111"],"URL":"https:\/\/doi.org\/10.1053\/j.jrn.2011.10.021","relation":{},"ISSN":["1051-2276"],"issn-type":[{"value":"1051-2276","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}